We finally evaluated whether selective inhibition of HECT proteins by a natural NEDD4 and WWP1 inhibitor from Brassicaceae displayed anti-SARS-CoV-2 activity, thus providing preclinical support for the possible development of clinical trials using this natural inhibitor in COVID-19 patients. Here, NEDD4 is linked to COVID-19.